A breakthrough study published in npj Aging just introduced a refreshing alternative: a urinary microRNA aging clock. By ...

Craif Inc. in Nagoya, Japan, working with Nagoya University's Institute of Innovation for Future Society, has developed a ...

Researchers developed and validated a non-invasive urinary microRNA aging clock using extracellular vesicle miRNAs from more ...

A new generation of aging tests is moving out of specialist labs and into everyday life, promising to tell you how old your ...

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory conditions. The target applies to a range of potential indications, from ...

Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ulcerative colitis. Read the latest analysis on the stock here.

Researchers from Marshall University and the University of Missouri have developed G2PDeep, an innovative web-based platform ...

-Nationwide access enabled through FedEx with prepaid shipping both ways.

Researchers have unveiled a breakthrough technology that could transform the way scientists build and study lab-grown brain ...

ALS is a debilitating paralytic disease characterized by the death of upper and lower motor neurons. Fortunately, ALS is ...